Last Posted: Dec-23-2016 2PM
Last Posted: Dec 22, 2016
- Individual DNA samples and health information sold by 23andMe.
Adam Shelin et al. Genetics in medicine : official journal of the American College of Medical Genetics 2016 Apr 18(4) 305-6 - ETHICAL AND GENETIC ASPECTS REGARDING PRESYMPTOMATIC TESTING FOR NEURODEGENERATIVE DISEASES.
Rev Med Chir Soc Med Nat Iasi. 2016 Jan-Mar;120(1):15-22. - Disclosure of research results in genetic studies of Parkinson's disease caused by LRRK2 mutations.
Pont-Sunyer Claustre et al. Movement disorders : official journal of the Movement Disorder Society 2015 Jun 30(7) 904-8 - Precision Medicine: Clarity for the Complexity of Dementia.
Cholerton Brenna et al. The American journal of pathology 2015 Dec - Candidate genes for Parkinson disease: Lessons from pathogenesis.
De Rosa Priscilla et al. Clinica chimica acta; international journal of clinical chemistry 2015 Sep 68-76 - Genetic variability in ABCB1, occupational pesticide exposure, and Parkinson's disease.
Narayan Shilpa et al. Environmental research 2015 Nov (Pt A) 98-106 - Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.
Nalls Mike A et al. Lancet Neurol 2015 Aug 10. - Biomarkers of Parkinson's disease: present and future.
Miller Diane B et al. Metab. Clin. Exp. 2015 Mar (3 Suppl 1) S40-6 - Epigenetic mechanisms in Parkinson's disease.
Feng Ya et al. J. Neurol. Sci. 2015 Feb 15. (1-2) 3-9 - Progress in unraveling the genetic etiology of Parkinson disease in a genomic era.
Verstraeten Aline et al. Trends Genet. 2015 Mar (3) 140-9 - The emergence of Parkinson disease among patients with Gaucher disease.
Elstein Deborah et al. Best Pract. Res. Clin. Endocrinol. Metab. 2015 Mar (2) 249-59 - The genetics of Parkinson's disease.
Mullin Stephen et al. Br. Med. Bull. 2015 Jun (1) 39-52 - The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease.
Lill Christina M et al. Alzheimers Dement 2015 Apr 29. - Relationship of age of onset and family history in Parkinson disease.
- ?-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease.
- Clinicians' attitudes toward general screening of the Ashkenazi-Jewish population for prevalent founder BRCA1/2 and LRRK2 mutations.
From CDC-Authored Genomics Publication Database
This database contains CDC-authored publications in public health genomics including infectious diseases, newborn screening, reproductive health, genetic testing, cancer, chronic diseases, birth defects and developmental disabilities, environmental and occupational health as well as laboratory, bioinformatics and statistical methods.
- Biomarkers of Parkinson's disease: present and future.
Miller Diane B et al. Metab. Clin. Exp. 2015 Mar 64(3 Suppl 1) S40-6 - Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.
Lill Christina M et al. PLoS Genet. 2012 8(3) e1002548
From HuGE Literature Finder Database
This database contains published literature on genetic associations and other human genome epidemiology
- Exonic rearrangements in the known Parkinson's disease-causing genes are a rare cause of the disease in South African patients.
Neuroscience letters 2016 Mar 619 168-171.
van der Merwe Celia, Carr Jonathan, Glanzmann Brigitte, Bardien Sora - Influence of genetic, biological and pharmacological factors on levodopa dose in Parkinson's disease.
Pharmacogenomics 2016 Mar .
Altmann Vivian, Schumacher-Schuh Artur F, Rieck Mariana, Callegari-Jacques Sidia M, Rieder Carlos Rm, Hutz Mara - PARK16 polymorphisms, interaction with smoking, and sporadic Parkinson's disease in Japan.
Journal of the neurological sciences 2016 Mar 362 47-52.
Miyake Yoshihiro, Tanaka Keiko, Fukushima Wakaba, Kiyohara Chikako, Sasaki Satoshi, Tsuboi Yoshio, Oeda Tomoko, Shimada Hiroyuki, Kawamura Nobutoshi, Sakae Nobutaka, Fukuyama Hidenao, Hirota Yoshio, Nagai Masaki, Nakamura Yoshikazu, - PARKIN Inactivation Links Parkinson's Disease to Melanoma.
Journal of the National Cancer Institute 2016 Mar 108 (3): .
Hu Hui-Han, Kannengiesser Caroline, Lesage Suzanne, André Jocelyne, Mourah Samia, Michel Laurence, Descamps Vincent, Basset-Seguin Nicole, Bagot Martine, Bensussan Armand, Lebbé Céleste, Deschamps Lydia, Saiag Philippe, Leccia Marie-Thérèse, Bressac-de-Paillerets Brigitte, Tsalamlal Amel, Kumar Rajiv, Klebe Stephan, Grandchamp Bernard, Andrieu-Abadie Nathalie, Thomas Luc, Brice Alexis, Dumaz Nicolas, Soufir Nad - Synaptotagmin XI in Parkinson's disease: New evidence from an association study in Spain and Mexico.
Journal of the neurological sciences 2016 Mar 362 321-5.
Sesar Angel, Cacheiro Pilar, López-López Marisol, Camiña-Tato Montserrat, Quintáns Beatriz, Monroy-Jaramillo Nancy, Alonso-Vilatela María-Elisa, Cebrián Ernesto, Yescas-Gómez Petra, Ares Begoña, Rivas María-Teresa, Castro Alfonso, Carracedo Angel, Sobrido María-Jes
.png)
No hay comentarios:
Publicar un comentario